Using magnesium to protect the brain after cardiac arrest
Official title: Neuroprotection Following Cardiac Arrest: A Randomized Control Trial of Magnesium
Run by NYU Langone Health · NCT06455514 · Data updated 2026-11-12
This study is testing if giving magnesium to people who have survived a cardiac arrest can help protect their brain and reduce injury.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 178 (estimated) |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | March 25, 2025 |
| Main results expected | March 30, 2026 |
| Study ends | June 30, 2026 |
| Registry record updated | April 7, 2026 |
| Trial ID | NCT06455514 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 85 who have achieved ROSC within 2 hours of cardiac arrest.
✕Probably not a fit
Patients with traumatic cardiac arrests or those who are expected to have life support withdrawn within 72 hours may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot interventional study aims to evaluate the safety and feasibility of administering magnesium sulfate as a neuroprotective treatment in patients who have achieved Return of Spontaneous Circulation (ROSC) following cardiac arrest. The study will measure serum markers of neuronal injury at specific time points after ROSC to gather preliminary data. With a limited sample size, the primary goal is to assess the precision and stability of these measures to inform future larger trials.
Why it matters
Potential benefit: If successful, this approach could improve neurological outcomes for patients who survive cardiac arrest.
How similar studies have gone: While this approach is novel, similar studies exploring neuroprotection after cardiac arrest have shown promise, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Documented post-cardiac arrest patient with Return of Spontaneous Circulation (ROSC) achieved \<2 hours prior to recruitment Exclusion Criteria: * Age \< 18 years or \> 85 years * Traumatic cardiac arrests * Unsustained ROSC (\<20 minutes) * Patient who is responsive/able to follow motor commands within 1 hour of achieving ROSC * Plan for withdrawal of life support within 72 hours of ROSC * Known pregnant women at the time of the cardiac arrest * Known prisoners at the time of the cardiac arrest * Subjects who have a medical o social condition that would make them inappropriate for the study based on the PI's or clinical team judgement.
Where it's running
-
NYU Langone Health
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Sam Parnia — NYU Langone Health
- Study coordinator: Anelly Gonzales
- Email: resuscitationlab@nyulangone.org
- Phone: 646-501-6923
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heartsight helps caregivers of kids after cardiac arrest manage uncertainty and fear
This pilot trial tests if the Heartsight information program is acceptable and helpful for caregivers of children who recently had a cardiac arrest.
-
Brain blood flow and brain regulation in critically ill kids
This study tests how blood flow in the brain behaves in critically ill children using a noninvasive ultrasound (TCD) to see if brain autoregulation patterns relate to outcomes.
-
Cardiopulmonary resuscitation with balloon occlusion of the descending aorta for hospitalized patients
This trial will test whether adding a balloon occlusion of the descending aorta (REBOA) to standard ACLS helps people having an in-hospital cardiac arrest regain and keep a pulse.
-
Digital serious game to improve critical care nurses' targeted temperature management skills and situational awareness.
We will test whether adding a digital serious game to regular lectures helps adult ICU nurses learn targeted temperature management and improve situational awareness.
-
Plasma proteins, metabolites, and platelet changes in extracorporeal CPR for cardiac arrest patients
This project will test whether patterns in blood proteins, small molecules, and platelet shape changes can help identify which adults with cardiac arrest might benefit from extracorporeal CPR.
-
Targeted Temperature Management at 33°C for in-hospital cardiac arrest
This trial tests whether cooling patients who remain unconscious after a resuscitated in-hospital cardiac arrest to 33°C improves survival with good brain function compared to keeping a normal, controlled temperature.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.